Evidence map›Paper›PMID 37995115›Full record

ArticleJMIR research protocols2023

Identifying Game-Based Digital Biomarkers of Cognitive Risk for Adolescent Substance Misuse: Protocol for a Proof-of-Concept Study.

Kammarauche Aneni, Ching-Hua Chen, Jenny Meyer, Youngsun T Cho, Zachary Chase Lipton, Saatvik Kher, Megan G Jiao, Isabella Gomati de la Vega, Feza Anaise Umutoni, Robert A McDougal and 1 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Kammarauche AneniChild Study Center, Yale School of Medicine, New Haven, CT, United States.ORCID https://orcid.org/0000-0001-5792-3605
Ching-Hua ChenCenter for Computational Health, IBM Research, Yorktown Heights, NY, United States.ORCID https://orcid.org/0000-0002-1020-0861
Jenny MeyerChild Study Center, Yale School of Medicine, New Haven, CT, United States.ORCID https://orcid.org/0009-0004-2016-9310
Youngsun T ChoChild Study Center, Yale School of Medicine, New Haven, CT, United States.ORCID https://orcid.org/0000-0001-8639-3869
Zachary Chase LiptonMachine Learning Department, School of Computer Science, Carnegie Mellon University, Pittsburg, PA, United States.ORCID https://orcid.org/0000-0002-3824-4241
Saatvik KherPomona College, Claremont, CA, United States.ORCID https://orcid.org/0009-0002-4329-9981
Megan G JiaoMcGovern Medical School, UTHealth Houston, Houston, TX, United States.ORCID https://orcid.org/0000-0003-2913-5083
Isabella Gomati de la VegaPontificia Universidad Javeriana, Bogota, Colombia.ORCID https://orcid.org/0000-0003-4633-7998
Feza Anaise UmutoniChild Study Center, Yale School of Medicine, New Haven, CT, United States.ORCID https://orcid.org/0009-0006-5871-3881
Robert A McDougalBiomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, United States.ORCID https://orcid.org/0000-0001-6394-3127
Lynn E FiellinChild Study Center, Yale School of Medicine, New Haven, CT, United States.ORCID https://orcid.org/0000-0003-0160-6613
Yale University · USCarnegie Mellon University · USFairfield University · USIBM (United States) · USPomona College · USPontificia Universidad Javeriana · COThe University of Texas Health Science Center at Houston · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS P30 DA029926
6 · The paper itself

Abstract

backgroundAdolescents at risk for substance misuse are rarely identified early due to existing barriers to screening that include the lack of time and privacy in clinic settings. Games can be used for screening and thus mitigate these barriers. Performance in a game is influenced by cognitive processes such as working memory and inhibitory control. Deficits in these cognitive processes can increase the risk of substance use. Further, substance misuse affects these cognitive processes and may influence game performance, captured by in-game metrics such as reaction time or time for task completion. Digital biomarkers are measures generated from digital tools that explain underlying health processes and can be used to predict, identify, and monitor health outcomes. As such, in-game performance metrics may represent digital biomarkers of cognitive processes that can offer an objective method for assessing underlying risk for substance misuse.

objectiveThis is a protocol for a proof-of-concept study to investigate the utility of in-game performance metrics as digital biomarkers of cognitive processes implicated in the development of substance misuse.

methodsThis study has 2 aims. In aim 1, using previously collected data from 166 adolescents aged 11-14 years, we extracted in-game performance metrics from a video game and are using machine learning methods to determine whether these metrics predict substance misuse. The extraction of in-game performance metrics was guided by literature review of in-game performance metrics and gameplay guidebooks provided by the game developers. In aim 2, using data from a new sample of 30 adolescents playing the same video game, we will test if metrics identified in aim 1 correlate with cognitive processes. Our hypothesis is that in-game performance metrics that are predictive of substance misuse in aim 1 will correlate with poor cognitive function in our second sample.

resultsThis study was funded by National Institute on Drug Abuse through the Center for Technology and Behavioral Health Pilot Core in May 2022. To date, we have extracted 285 in-game performance metrics. We obtained institutional review board approval on October 11, 2022. Data collection for aim 2 is ongoing and projected to end in February 2024. Currently, we have enrolled 12 participants. Data analysis for aim 2 will begin once data collection is completed. The results from both aims will be reported in a subsequent publication, expected to be published in late 2024.

conclusionsScreening adolescents for substance use is not consistently done due to barriers that include the lack of time. Using games that provide an objective measure to identify adolescents at risk for substance misuse can increase screening rates, early identification, and intervention. The results will inform the utility of in-game performance metrics as digital biomarkers for identifying adolescents at high risk for substance misuse. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/46990.

Indexed as

adolescentadolescent substance misusebarrierbiomarkercognitioncognitive risk factorsdigitalgamegame-based digital biomarkersgame-based measurement of cognitive functionmisusescreeningsubstanceuse

Identifiers

PMID37995115
PMCPMC10704313
OpenAlexW4387316687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.